You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 111 No. 6, June 1963 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Histoplasmosis, 1962

J. SCHWARZ, MD; G. L. BAUM, MD

Arch Intern Med. 1963;111(6):710-718.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In 1956 we discussed the history of histoplasmosis1 and the developments of 50 years since the discovery of the disease by Samuel T. Darling.2 Since 1956, much new knowledge has accumulated—an effective therapeutic agent (amphotericin B) has become available,3 and essential epidemiologic and anatomical data have been brought forward contributing to the understanding of the disease.

It is universally accepted that the lung is, for all practical purposes, the only portal of entrance for the cells of Histoplasma capsulatum and the site of the primary infection. This statement is based on the demonstration of primary foci in the lungs of a large segment of the population in the endemic area by anatomical methods with demonstration of organisms in these frequently calcified, primary lesions.4-8

Epidemiologic studies have been another source of information contributing to this pathogenic opinion. Furcolow and others9,10 have shown that the so-called epidemics . . . [Full Text PDF of this Article]


Author Affiliations

CINCINNATI

Associate Professor of Pathology (Dr. Schwarz); Assistant Professor of Internal Medicine (Dr. Baum).; From the Clinical Laboratories, Jewish Hospital; the Pulmonary Disease Section, Medical Services, Veterans Administration Hospital; Departments of Pathology, Medicine, and Dermatology, University of Cincinnati, College of Medicine.


Footnotes

Received for publication Oct. 13, 1962; accepted Oct. 30.

This study was aided in part by Grant E-576 of the National Institutes of Health.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.